查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1636769

2030 年消费者基因体学市场预测：按测试类型、技术、分销管道、应用、最终用户和地区进行的全球分析

Consumer Genomics Market Forecasts to 2030 - Global Analysis By Test Type (Health Risk Testing, Traits Testing, Carrier Screening and Pharmacogenomics), Technology, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球消费者基因组学市场预计在 2024 年达到 19.7 亿美元，到 2030 年将达到 82.1 亿美元，预测期内的复合年增长率为 26.8%。

消费者基因体学是基因体学的一个分支，直接向个人提供基因检测服务，让他们探索自己的 DNA，了解自己的祖先、健康、保健和个人特征。这使消费者能够优化他们的生活方式选择，定制他们的医疗保健，并了解他们的疾病遗传倾向。消费者基因组学利用次世代定序和基因型鉴定等最尖端科技，使基因资讯更容易取得且价格更实惠。直接面向消费者的平台正在透过改变个人医疗保健和增加有关遗传影响的了解来帮助扩大该行业的知名度。

根据国际癌症研究机构（IARC）的数据，到 2040 年未确诊的癌症病例数预计将达到 3,020 万人。

人们对血统和遗传遗产的兴趣日益浓厚

人们对遗传遗产和祖先的兴趣日益浓厚，对消费者基因组学领域产生了重大影响。随着人们想要更多地了解自己的祖先和种族背景，DNA检测套组的需求量很大。许多变数促成了这一趋势，包括广泛的营销和直接面向消费者的测试服务。由于许多消费者渴望了解更多资讯并与祖先建立联繫，因此进行的测试数量创下了历史新高。 23andMe 和 Ancestry 等公司透过建立庞大的资料库从这项兴趣中获利，这些资料库使得基因检测对祖先研究和个人发现更有吸引力。

技术和资料整合挑战

测试程序缺乏标准化是一个重大问题，可能导致多个操作员的结果不一致。此外，缺乏法律规范可能会使人们对基因资料解释的可靠性和正确性产生怀疑，从而削弱客户信任。关键问题包括资料安全和隐私。由于担心滥用和未授权存取，人们越来越担心自己的基因资料的收集、储存和使用。解决这些问题对于建立信任和确保长期市场成长至关重要。

扩大医疗保健和健康服务

基因组学的发展使人们能够了解自己对各种疾病的遗传易感性的信息，从而实现早期发现和主动的健康管理。各种健康公司正在利用基因资料提供个人化的健身、饮食和生活方式提案，以改善整体健康。此外，药物基因体学，即利用基因资讯定製药物治疗，正被用于最大限度地提高治疗效果和最大限度地减少副作用。随着越来越多的健康计划和医疗保健专业人员利用基因技术，消费者基因组学市场正在扩大，从而提高了个人化健康解决方案的有效性和可及性。

隐私和资料安全问题

由于资料外洩、未授权存取和滥用的风险，消费者通常不愿意向公司提供他们的 DNA 资讯。随着线上基因检测平台越来越受欢迎，基因资料的储存和交换引发了人们对个人资料安全的严重担忧。这些担忧因基因资讯可能被用于歧视目的而加剧，包括在保险和职场。因此，强而有力的资料保护政策、透明的同意程序和法规合规性对于赢得客户信任和确保市场扩张至关重要。

COVID-19 的影响

COVID-19 疫情对消费者基因组学市场产生了多方面的影响。一方面，随着消费者寻求更好地了解自己患有包括新冠肺炎在内的疾病的遗传风险的方法，疫情增加了人们对个人健康、保健和基因检测的关注。另一方面，物流挑战、测试处理延迟和供应链中断暂时影响了市场。然而，家庭健康检测需求的不断增长和向数位化医疗的转变促进了消费者基因组学市场的长期成长。

预测期内，基因型鉴定型市场预计将成为最大的市场

由于次世代定序（NGS）的出现使得基因检测更加容易获得、更实惠、更准确，从而促进了其广泛应用，因此基因型鉴定领域估计将是最大的领域。此外，消费者越来越寻求个人化的健康见解来主动管理他们的健康，从而导致对基因检测服务的需求激增。数位健康技术的融合进一步推动了这一趋势，这些技术增强了基因组资料的分析和应用，使个人能够做出明智的生活方式和医疗保健决策。

预计预测期内医疗保健提供者部门将以最高的复合年增长率成长。

由于对个人化医疗的日益重视和对预防性医疗保健解决方案的需求不断增长，预计医疗保健提供者部门将在预测期内实现最高的复合年增长率。随着医疗保健专业人员意识到基因洞察的价值，他们正在将基因组资讯整合到患者护理中，以客製化治疗并改善健康结果。消费者对基因对健康影响的认识不断提高，这鼓励了供应商提供基因检测服务。此外，基因组学技术的进步和法律规范正在促进医疗保健提供者和基因组学相关企业之间的合作，进一步推动市场成长。

占比最大的地区：

由于医疗保健支出的增加、慢性病盛行率的上升以及对个人化医疗的认识的不断提高，预计亚太地区将在预测期内占据最大的市场占有率。此外，次世代定序（NGS）等基因组技术的进步使得基因检测更便宜、更容易取得。此外，该地区的智慧型手机普及率和网路普及率正在不断提高，这推动了直接面向消费者 (DTC) 的基因检测服务的成长。

复合年增长率最高的地区：

预计北美地区在预测期内的复合年增长率最高。这是由于消费者对个人化医疗意识的不断增强、对家庭基因检测的需求不断增加以及基因组技术的进步。该地区受益于发达的医疗保健基础设施、便利的基因检测服务和高可支配收入。此外，北美对基因检测和资料隐私法有强而有力的监管支持，进一步鼓励消费者参与。智慧医疗保健和健康趋势的兴起也推动了该地区的市场成长。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业进行基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球消费者基因体学市场（依测试类型）

  • 健康风险测试
  • 特性测试
  • 携带者筛检
  • 药物基因组学

6. 全球消费者基因体学市场（依技术划分）

  • 次世代定序（NGS）
  • 聚合酵素链锁反应（PCR）
  • 微阵列
  • 基于 CRISPR 的技术
  • 核酸萃取与精製
  • 基因型鉴定
  • 其他技术

7. 全球消费者基因体学市场按分销管道划分

  • 零售商
  • 网路平台
  • 医疗设施

8. 全球消费者基因体学市场（按应用）

  • 血统和种族测试
  • 健康与保健
  • 个人化医疗
  • 遗传相关性
  • 诊断
  • 生活方式、健康与营养
  • 生殖健康
  • 运动营养与健康
  • 其他用途

9. 全球消费者基因体学市场（依最终用户划分）

  • 製药公司
  • 医疗保健提供者
  • 研究所
  • 个人消费者
  • 其他最终用户

第 10 章。

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Ancestry.com LLC
  • MyHeritage Ltd.
  • Helix OpCo LLC
  • Living DNA Ltd.
  • Veritas Genetics
  • Mapmygenome India Ltd.
  • Pathway Genomics Corporation
  • Color Genomics, Inc.
  • Invitae Corporation
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Fulgent Genetics, Inc.
  • Nebula Genomics
  • Orig3n, Inc.
  • EasyDNA
  • TellmeGen
  • Genetic Technologies Limited
Product Code: SMRC28411

According to Stratistics MRC, the Global Consumer Genomics Market is accounted for $1.97 billion in 2024 and is expected to reach $8.21 billion by 2030 growing at a CAGR of 26.8% during the forecast period. Consumer genomics refers to the branch of genomics that provides genetic testing services directly to individuals, enabling them to explore their DNA for insights into ancestry, health, wellness, and personal traits. It enables consumers to optimize lifestyle choices, customize healthcare, and comprehend genetic predispositions to diseases. Consumer genomics provides easily available and reasonably priced genetic information by leveraging cutting-edge technology such as next-generation sequencing and genotyping. Direct-to-consumer platforms have helped this industry grow in popularity by transforming personal healthcare and raising knowledge of genetic influences.

According to the International Agency for Research on Cancer (IARC), the number of un-diagnosed cancer cases is expected to reach 30.2 MN, by 2040.

Market Dynamics:

Driver:

Increased interest in ancestry and genetic heritage

Growing interest in genetic heritage and ancestry is having a big impact on the consumer genomics sector. DNA testing kits are in high demand as people try to learn more about their ancestry and ethnic backgrounds. Numerous variables, such as extensive marketing and the availability of direct-to-consumer testing services, are contributing to this trend. A record number of tests are being undertaken because many consumers are driven by a desire to learn more about their ancestry and connect with their ancestors. Businesses such as 23andMe and Ancestry have benefited from this interest by building extensive databases that increase the allure of genetic testing for ancestry research and personal discovery.

Restraint:

Technological and data integration challenges

Lack of standardization in testing procedures is a significant problem that can provide inconsistent outcomes across several businesses. Furthermore, the lack of regulatory supervision casts doubt on the dependability and correctness of interpreting genetic data, which could erode customer confidence. Critical issues include data security and privacy; people are growing more concerned about the collection, storage, and use of their genetic data out of concern about abuse or illegal access. Resolving these issues is crucial to building trust and guaranteeing the market's long-term growth.

Opportunity:

Expansion of healthcare and wellness services

The development of genomics has given people access to information about their genetic susceptibilities to various illnesses, enabling early disease detection and proactive health management. In order to improve overall health results, a variety of wellness companies are using genetic data to provide individualized fitness, food, and lifestyle recommendations. Additionally, pharmacogenomics the customization of pharmaceutical therapies using genetic information is being employed to maximize therapeutic efficacy and minimize side responses. The market for consumer genomics is growing as more wellness programs and healthcare professionals use genetics, increasing the effectiveness and accessibility of personalized health solutions.

Threat:

Privacy and data security concerns

Consumers are frequently hesitant to give businesses their DNA information because of the possible dangers of data breaches, illegal access, and abuse. With the growing popularity of online genetic testing platforms, the storage and exchange of genetic data raises serious concerns regarding the security of personal data. These worries are further heightened by the possibility that genetic information would be utilized for discriminatory purposes, including in insurance or the workplace. Therefore, it is essential to have strong data protection policies, transparent consent procedures, and regulatory compliance in order to gain the trust of customers and guarantee market expansion

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the consumer genomics market. On one hand, the pandemic led to an increased focus on personal health, wellness, and genetic testing as consumers sought ways to better understand their genetic risks for diseases, including COVID-19. On the other hand, logistical challenges, delays in test processing, and disruptions in supply chains temporarily affected the market. However, the growing demand for at-home health testing and the shift to digital healthcare contributed to the long-term growth of the consumer genomics market.

The genotyping segment is expected to be the largest during the forecast period

The genotyping segment is estimated to be the largest, due to the emergence of next-generation sequencing (NGS) has made genetic testing more accessible, affordable, and accurate, facilitating widespread adoption. Additionally, consumers are increasingly seeking personalized health insights to manage their well-being proactively, leading to a surge in demand for genetic testing services. This trend is further supported by the integration of digital health technologies, which enhance the analysis and application of genomic data, empowering individuals to make informed lifestyle and healthcare decisions.

The healthcare providers segment is expected to have the highest CAGR during the forecast period

The healthcare providers segment is anticipated to witness the highest CAGR during the forecast period, due to the rising emphasis on personalized medicine and the increasing demand for preventive healthcare solutions. As healthcare professionals recognize the value of genetic insights, they are integrating genomic information into patient care to tailor treatments and improve health outcomes. The growing awareness among consumers about the influence of genetics on health is prompting providers to offer genetic testing services. Additionally, advancements in genomic technologies and supportive regulatory frameworks are facilitating collaborations between healthcare providers and genomics companies, further driving market growth.

Region with largest share:

Asia Pacific is expected to have the largest market share during the forecast period due to increasing healthcare expenditure, rising prevalence of chronic diseases, and growing awareness of personalized medicine. Additionally, advancements in genomic technologies, such as next-generation sequencing (NGS), are making genetic testing more affordable and accessible. Furthermore, the increasing adoption of smartphones and internet penetration in the region is facilitating the growth of direct-to-consumer (DTC) genetic testing services.

Region with highest CAGR:

During the forecast period, the North America region is anticipated to register the highest CAGR, owing to rising consumer awareness of personalized healthcare, growing demand for at-home genetic testing, and advancements in genomic technologies. The region benefits from a well-established healthcare infrastructure, with easy access to genetic testing services and a high level of disposable income. Additionally, North America sees strong regulatory support for genetic research and data privacy laws, further encouraging consumer participation. The widespread adoption of smart healthcare and wellness trends also propels market growth in the region.

Key players in the market

Some of the key players profiled in the Consumer Genomics Market include Ancestry.com LLC, MyHeritage Ltd., Helix OpCo LLC, Living DNA Ltd., Veritas Genetics, Mapmygenome India Ltd., Pathway Genomics Corporation, Color Genomics, Inc., Invitae Corporation, Thermo Fisher Scientific Inc., Illumina, Inc., Fulgent Genetics, Inc., Nebula Genomics, Orig3n, Inc., EasyDNA, TellmeGen, and Genetic Technologies Limited.

Key Developments:

In July 2024, Ancestry Launches NEW Interactive DNA Compare Experience to Help Fans Discover How Their DNA Compares to More Than 15 World-Class Athletes.

In December 2023, Helix and Sanford Health Partner on 100K Population Genomics Health Initiative in Upper Midwest. Genomics company Helix and healthcare system Sanford Health announced a population genomics partnership to bring precision medicine to rural communities in the Upper Midwest.

Test Types Covered:

  • Health Risk Testing
  • Traits Testing
  • Carrier Screening
  • Pharmacogenomics

Technologies Covered:

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • CRISPR-based Technologies
  • Nucleic Acid Extraction and Purification
  • Genotyping
  • Other Technologies

Distribution Channels Covered:

  • Retail Stores
  • Online Platforms
  • Healthcare Facilities

Applications Covered:

  • Ancestry & Ethnicity Testing
  • Health & Wellness
  • Personalized Medicine
  • Genetic Relatedness
  • Diagnostics
  • Lifestyle, Wellness, and Nutrition
  • Reproductive Health
  • Sports Nutrition and Health
  • Other Applications

End Users Covered:

  • Pharmaceutical Companies
  • Healthcare Providers
  • Research Institutions
  • Individual Consumers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Consumer Genomics Market, By Test Type

  • 5.1 Introduction
  • 5.2 Health Risk Testing
  • 5.3 Traits Testing
  • 5.4 Carrier Screening
  • 5.5 Pharmacogenomics

6 Global Consumer Genomics Market, By Technology

  • 6.1 Introduction
  • 6.2 Next-Generation Sequencing (NGS)
  • 6.3 Polymerase Chain Reaction (PCR)
  • 6.4 Microarray
  • 6.5 CRISPR-based Technologies
  • 6.6 Nucleic Acid Extraction and Purification
  • 6.7 Genotyping
  • 6.8 Other Technologies

7 Global Consumer Genomics Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail Stores
  • 7.3 Online Platforms
  • 7.4 Healthcare Facilities

8 Global Consumer Genomics Market, By Application

  • 8.1 Introduction
  • 8.2 Ancestry & Ethnicity Testing
  • 8.3 Health & Wellness
  • 8.4 Personalized Medicine
  • 8.5 Genetic Relatedness
  • 8.6 Diagnostics
  • 8.7 Lifestyle, Wellness, and Nutrition
  • 8.8 Reproductive Health
  • 8.9 Sports Nutrition and Health
  • 8.10 Other Applications

9 Global Consumer Genomics Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical Companies
  • 9.3 Healthcare Providers
  • 9.4 Research Institutions
  • 9.5 Individual Consumers
  • 9.6 Other End Users

10 Global Consumer Genomics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Ancestry.com LLC
  • 12.2 MyHeritage Ltd.
  • 12.3 Helix OpCo LLC
  • 12.4 Living DNA Ltd.
  • 12.5 Veritas Genetics
  • 12.6 Mapmygenome India Ltd.
  • 12.7 Pathway Genomics Corporation
  • 12.8 Color Genomics, Inc.
  • 12.9 Invitae Corporation
  • 12.10 Thermo Fisher Scientific Inc.
  • 12.11 Illumina, Inc.
  • 12.12 Fulgent Genetics, Inc.
  • 12.13 Nebula Genomics
  • 12.14 Orig3n, Inc.
  • 12.15 EasyDNA
  • 12.16 TellmeGen
  • 12.17 Genetic Technologies Limited

List of Tables

  • Table 1 Global Consumer Genomics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Consumer Genomics Market Outlook, By Test Type (2022-2030) ($MN)
  • Table 3 Global Consumer Genomics Market Outlook, By Health Risk Testing (2022-2030) ($MN)
  • Table 4 Global Consumer Genomics Market Outlook, By Traits Testing (2022-2030) ($MN)
  • Table 5 Global Consumer Genomics Market Outlook, By Carrier Screening (2022-2030) ($MN)
  • Table 6 Global Consumer Genomics Market Outlook, By Pharmacogenomics (2022-2030) ($MN)
  • Table 7 Global Consumer Genomics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 8 Global Consumer Genomics Market Outlook, By Next-Generation Sequencing (NGS) (2022-2030) ($MN)
  • Table 9 Global Consumer Genomics Market Outlook, By Polymerase Chain Reaction (PCR) (2022-2030) ($MN)
  • Table 10 Global Consumer Genomics Market Outlook, By Microarray (2022-2030) ($MN)
  • Table 11 Global Consumer Genomics Market Outlook, By CRISPR-based Technologies (2022-2030) ($MN)
  • Table 12 Global Consumer Genomics Market Outlook, By Nucleic Acid Extraction and Purification (2022-2030) ($MN)
  • Table 13 Global Consumer Genomics Market Outlook, By Genotyping (2022-2030) ($MN)
  • Table 14 Global Consumer Genomics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 15 Global Consumer Genomics Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 16 Global Consumer Genomics Market Outlook, By Retail Stores (2022-2030) ($MN)
  • Table 17 Global Consumer Genomics Market Outlook, By Online Platforms (2022-2030) ($MN)
  • Table 18 Global Consumer Genomics Market Outlook, By Healthcare Facilities (2022-2030) ($MN)
  • Table 19 Global Consumer Genomics Market Outlook, By Application (2022-2030) ($MN)
  • Table 20 Global Consumer Genomics Market Outlook, By Ancestry & Ethnicity Testing (2022-2030) ($MN)
  • Table 21 Global Consumer Genomics Market Outlook, By Health & Wellness (2022-2030) ($MN)
  • Table 22 Global Consumer Genomics Market Outlook, By Personalized Medicine (2022-2030) ($MN)
  • Table 23 Global Consumer Genomics Market Outlook, By Genetic Relatedness (2022-2030) ($MN)
  • Table 24 Global Consumer Genomics Market Outlook, By Diagnostics (2022-2030) ($MN)
  • Table 25 Global Consumer Genomics Market Outlook, By Lifestyle, Wellness, and Nutrition (2022-2030) ($MN)
  • Table 26 Global Consumer Genomics Market Outlook, By Reproductive Health (2022-2030) ($MN)
  • Table 27 Global Consumer Genomics Market Outlook, By Sports Nutrition and Health (2022-2030) ($MN)
  • Table 28 Global Consumer Genomics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 29 Global Consumer Genomics Market Outlook, By End User (2022-2030) ($MN)
  • Table 30 Global Consumer Genomics Market Outlook, By Pharmaceutical Companies (2022-2030) ($MN)
  • Table 31 Global Consumer Genomics Market Outlook, By Healthcare Providers (2022-2030) ($MN)
  • Table 32 Global Consumer Genomics Market Outlook, By Research Institutions (2022-2030) ($MN)
  • Table 33 Global Consumer Genomics Market Outlook, By Individual Consumers (2022-2030) ($MN)
  • Table 34 Global Consumer Genomics Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.